Clinicopathological and prognostic implications of EGFR mutations subtypes in Moroccan non-small cell lung cancer patients: A first report.
Sara BoukansaIsmail MouhrachFatima El AgySanae El BardaiLaila BouguenouchMounia SerrajBouchra AmaraYassine OuadnouniMohamed SmahiBadreeddine AlamiNawfel MellasZineb BenbrahimHinde El FatemiPublished in: PloS one (2024)
This study highlights the relevance of EGFR mutation status in NSCLC patients, particularly in therapeutic decision-making. The association between smoking history and rare mutations suggests the need for tailored approaches. The survival advantage for patients with common EGFR mutations underscores the significance of personalized treatment strategies.
Keyphrases
- small cell lung cancer
- epidermal growth factor receptor
- tyrosine kinase
- decision making
- end stage renal disease
- newly diagnosed
- ejection fraction
- advanced non small cell lung cancer
- single cell
- prognostic factors
- brain metastases
- stem cells
- patient reported outcomes
- mesenchymal stem cells
- patient reported
- free survival